Clinical Trials Directory

Trials / Suspended

SuspendedNCT00483912

Albumindialysis in Acute Pancreatitis

Molecular Adsorbent Recirculating System (MARS) in Severe Acute Pancreatitis

Status
Suspended
Phase
N/A
Study type
Interventional
Enrollment
Sponsor
Tampere University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers

Summary

The incidence of acute pancreatitis has been doubled during last three decades in Finland. Alcohol is the main cause of acute pancreatitis in Finland accounting for 70 % of cases. Although the mortality of acute pancreatitis has been decreased it still appears and especially early multiple organ failure is the main cause of all deaths. Multiple organ failure in the early course of the disease is thought to be caused by the release of cytokines. Molecular adsorbent recirculating system (MARS) has shown to decrease mortality in acute alcohol hepatitis and paracetamol intoxication. Also it has been shown to improve kidney function due to hypoperfusion and tubulus necrosis and overrule decrease mortality in patients with multiple organ failure due to different reasons. A part of patients with acute alcoholic pancreatitis may have so-called fat liver already on admission. It has been shown that the highest mortality is especially associated those with early liver and kidney failure. MARS treatment has never earlier been used in the patients with acute alcoholic pancreatitis and early organ failure. In this study we randomize patients with acute alcoholic pancreatitis and early multiple organ failure (Sofa score\>2) to two groups: 1) Standard pancreatitis treatment in intensive care unit and 2) Standard pancreatitis treatment in intensive care unit with 5 MARS sessions.

Conditions

Interventions

TypeNameDescription
DEVICEMolecular adsorbent recirculating system

Timeline

First posted
2007-06-08
Last updated
2007-06-08

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT00483912. Inclusion in this directory is not an endorsement.